These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3275214)

  • 1. Ultrastructural localization of HLA-DR and HLA-DQ molecules in Langerhans cells and B cells: an immunoelectronmicroscopic study.
    Vermeer BJ; Mommaas AM; Wijsman MC; Koning F; Claas FH
    Reg Immunol; 1988; 1(2):85-91. PubMed ID: 3275214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
    J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of HLA class II molecules in epidermal Langerhans cells in situ.
    Mommaas AM; Mulder AA; Out CJ; Girolomoni G; Koerten HK; Vermeer BJ; Koning F
    Eur J Immunol; 1995 Feb; 25(2):520-5. PubMed ID: 7875214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture.
    Messadi DV; Pober JS; Murphy GF
    Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
    Pesando JM; Graf L; Hoffman P
    J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
    Walsh LJ; Seymour GJ; Powell RN
    J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
    Altomonte M; Pucillo C; Damante G; Maio M
    J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
    Lotteau V; Teyton L; Burroughs D; Charron D
    Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cells and T-lymphocytes in the normal human ectocervix defined by monoclonal antibodies and electron microscopy.
    Roig de Vargas-Linares C
    Microsc Electron Biol Celular; 1989 Jun; 13(1):53-63. PubMed ID: 2636973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II antigens on dendritic cells from the synovial fluids of patients with inflammatory arthritis.
    Knight SC; Fryer P; Griffiths S; Harding B; Dixey J; Mansell B
    Clin Exp Immunol; 1989 Oct; 78(1):19-25. PubMed ID: 2805419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Lysostrip" experiments with HLA class-II antigens. I. Independent surface mobility of DQ and DR molecules.
    Kałamarz M; Matej H
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):651-7. PubMed ID: 2487373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells.
    Fermand JP; Schmitt C; Brouet JC
    Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.
    Ballardini G; Bianchi FB; Mirakian R; Fallani M; Pisi E; Bottazzo GF
    Clin Exp Immunol; 1987 Oct; 70(1):35-46. PubMed ID: 3319302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.